Key result
A single dose of the inactivated chimeric rFAdV-4-fiber/8b vaccine provided full clinical protection and 100% survival against both FAdV-4 and FAdV-8b challenges in SPF chickens.
Why the study?
HHS and IBH co-infections are frequently reported clinically, but there are no commercially available bivalent vaccines to prevent and control both FAdV-4 and FAdV-8b.
Does an inactivated chimeric rFAdV-4-fiber/8b vaccine provide protection against FAdV-4 and FAdV-8b challenge in an in vivo model?
Does an inactivated chimeric rFAdV-4-fiber/8b vaccine provide protection against FAdV-4 and FAdV-8b challenge in an in vivo model?
Absolute Event Rate: 100% vs 50%
The chimeric rFAdV-4-fiber/8b virus can serve as a potential bivalent vaccine for the control and prevention of hepatitis-hydropericardium syndrome and inclusion body hepatitis in poultry.
Fowl adenovirus serotype 4 (FAdV-4) and FAdV-8b are causative agents of hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH), respectively. HHS and IBH co-infections were often reported in clinical, yet there are no commercially available bivalent vaccines for prevention and control of both FAdV-4 and -8b. In the present study, a chimeric FAdV-4 was firstly generated by substituting fiber-1 of FAdV-4 with fiber of FAdV-8b. The chimeric virus, rFAdV-4-fiber/8b, exhibited similar replication ability in vitro and pathogenicity in vivo to the parental wild type FAdV-4. A single dosage of vaccination with the inactivated rFAdV-4-fiber/8b induced high antibody titers against fiber-2 of FAdV-4 and fiber of FAdV-8b and provided full protection against FAdV-4 and -8b challenge. These results demonstrated that fiber of FAdV-8b could replace the role of fiber-1 of FAdV-4 in the process of viral infection, and rFAdV-4-fiber/8b could be used to make a potential bivalent vaccine for the control and prevention of HHS and IBH.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied Hepatitis-hydropericardium syndrome and inclusion body hepatitis (n=50). Inactivated rFAdV-4-fiber/8b vaccine vs. Unvaccinated (Sham control) was evaluated on Survival rate after virulent FAdV-4 challenge. A single dose of the inactivated chimeric rFAdV-4-fiber/8b vaccine provided full clinical protection and 100% survival against both FAdV-4 and FAdV-8b challenges in SPF chickens.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: